Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Squamous Cell Carcinoma
Age: Adult
Dose: Intravenous, Intramuscular, or Subcutaneous – 0.25-0.5 unit/kg (10 to 20 unit/m²)
Frequency: weekly or twice weekly
Indication: Testicular Carcinoma
Age: Adult
Dose: Intravenous, Intramuscular, or Subcutaneous – 0.25-0.5 unit/kg (10 to 20 unit/m²)
Frequency: weekly or twice weekly

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: Not recommended
Note: Not recommended

Renal Dose

Clinical InformationAdministration Information
Condition: Renal Impairment CrCl greater than 50 mL/min
Dose: Dose:
Note: Dose adjustment not necessary
Condition: Renal Impairment CrCl 40-50 mL/min
Dose: Dose:
Note: 70% of normal dose
Administration
  • For hospital use only
  • Must be diluted properly
Side Effect

Drug Interaction

Drug NameRisk Factors
Previous or concurrent radiotherapy to the chest
Increased incidence and severity of lung toxicity
Vinca Alkaloids (Vincristine, Vinblastine, Vinorelbine)
May result in a syndrome corresponding to morbus Raynaud

Disease Interaction

Disease NameRisk Factors
Severe Pulmonary Disease
Risk of fatal lung toxicity

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store between 2-8°C. Protect from light and should not be used after the expiration date is reached.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.